OVID: Ovid Therapeutics Inc. Stock

by  •  • Comments Off on OVID: Ovid Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 219.51
Enterprise Value ($M) 192.47
Book Value ($M) 87.80
Book Value / Share 1.24
Price / Book 2.50
NCAV ($M) 53.37
NCAV / Share 0.75
Price / NCAV 4.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.50
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 9.55
Current Ratio 9.55

Balance Sheet (mrq) ($M)
Current Assets 109.60
Assets 144.03
Liabilities 56.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.39
Operating Income -59.28
Net Income -52.34
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -45.78
Cash from Investing -2.58
Cash from Financing 30.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Madison Avenue Partners, LP 5.20 1.09
02-14 13G/A Levin Jeremy M 9.40 -4.66
02-12 13G/A Rubric Capital Management LP 7.52 -22.15
01-29 13G BlackRock Inc. 6.10 259.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-29 32,716 186,040 17.59
2024-04-26 12,290 25,768 47.69
2024-04-25 7,210 47,951 15.04
2024-04-24 9,247 46,330 19.96

(click for more detail)

Similar Companies
OPK – OPKO Health, Inc. OPTN – OptiNose, Inc.
ORIC – ORIC Pharmaceuticals, Inc. PASG – Passage Bio, Inc.
PBYI – Puma Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io